Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Jan-23 8:29 PM View:  | Jounce Therapeutics, Inc. (JNCE) | 10-Jan-23 | Sale | 9,182 | $1.12 | $10,283.80 | (8%) 119.26K to 110.08K | |
| 11-Jan-23 8:29 PM View: | Jounce Therapeutics, Inc. (JNCE) | 09-Jan-23 | Sale | 7,452 | $1.10 | $8,197.20 | (6%) 126.72K to 119.26K | |
| 03-Aug-22 8:29 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Aug-22 | Grant | 20,000 | -- | -- | 19% 106.72K to 126.72K | |
| 03-Feb-22 7:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-22 | Grant | 42,500 | -- | -- | 66% 64.22K to 106.72K | |
| 11-Jan-22 8:55 PM View: | Jounce Therapeutics, Inc. (JNCE) | 10-Jan-22 | Market Sale | 6,205 | $6.65 | $41,263.20 | (9%) 70.42K to 64.22K | (2%) |
| 11-Jan-22 8:55 PM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-22 | Market Sale | 3,468 | $7.30 | $25,316.40 | (5%) 73.89K to 70.42K | 7% |
| 03-Feb-21 5:45 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-21 | Grant | 26,700 | -- | -- | 57% 47.19K to 73.89K | |
| 25-Jan-21 5:36 PM View: | Jounce Therapeutics, Inc. (JNCE) | 22-Jan-21 | Option Exercise | 10,000 | $5.47 | $54,750.00 | 18% 55.19K to 65.19K | |
| 25-Jan-21 5:36 PM View: | Jounce Therapeutics, Inc. (JNCE) | 22-Jan-21 | Market Option Sale (Planned) | 10,000 | $11.95 | $119,500.00 | (15%) 65.19K to 55.19K | |
| 25-Jan-21 5:36 PM View: | Jounce Therapeutics, Inc. (JNCE) | 22-Jan-21 | Market Sale (Planned) | 8,000 | $11.95 | $95,600.00 | (14%) 55.19K to 47.19K | |
| 11-Jan-21 6:19 AM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Jan-21 | Market Sale | 3,340 | $7.00 | $23,380.00 | (6%) 58.53K to 55.19K | (4%) |
| 11-Jan-21 6:19 AM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-21 | Market Sale | 2,879 | $6.76 | $19,462.00 | (5%) 61.41K to 58.53K | (8%) |
| 18-Aug-20 8:29 PM View: | Jounce Therapeutics, Inc. (JNCE) | 18-Aug-20 | Market Sale | 744 | $4.71 | $3,504.24 | (1%) 62.15K to 61.41K | (38%) |
| 18-Aug-20 8:29 PM View: | Jounce Therapeutics, Inc. (JNCE) | 17-Aug-20 | Market Sale | 454 | $4.86 | $2,206.44 | (< 1%) 62.61K to 62.15K | (33%) |
| 18-Aug-20 8:29 PM View: | Jounce Therapeutics, Inc. (JNCE) | 14-Aug-20 | Market Sale | 984 | $4.64 | $4,565.76 | (2%) 63.59K to 62.61K | (40%) |
| 04-Feb-20 9:01 PM View: | Jounce Therapeutics, Inc. (JNCE) | 03-Feb-20 | Grant | 30,000 | -- | -- | 89% 33.59K to 63.59K | |
| 10-Jan-20 8:53 AM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-20 | Market Sale | 2,624 | $7.78 | $20,414.70 | (7%) 36.21K to 33.59K | 17% |
| 16-Aug-19 9:00 PM View: | Jounce Therapeutics, Inc. (JNCE) | 16-Aug-19 | Market Sale | 1,018 | $3.92 | $3,990.56 | (3%) 37.23K to 36.21K | (65%) |
| 16-Aug-19 9:00 PM View: | Jounce Therapeutics, Inc. (JNCE) | 15-Aug-19 | Market Sale | 648 | $4.00 | $2,592.00 | (2%) 37.88K to 37.23K | (62%) |
| 16-Aug-19 9:00 PM View: | Jounce Therapeutics, Inc. (JNCE) | 14-Aug-19 | Market Sale | 670 | $4.10 | $2,747.00 | (2%) 38.55K to 37.88K | (58%) |
| 05-Feb-19 6:03 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-19 | Grant | 22,250 | -- | -- | 137% 16.3K to 38.55K | |
| 15-Aug-18 5:28 PM View: | Jounce Therapeutics, Inc. (JNCE) | 13-Aug-18 | Grant | 14,400 | -- | -- | 758% 1.9K to 16.3K | |
| 18-Jun-18 6:24 PM View: | Jounce Therapeutics, Inc. (JNCE) | 15-Jun-18 | Market Purchase | 1,900 | $7.84 | $14,896.00 | 100% 0 to 1.9K | (17%) |
| 16-Feb-17 2:16 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Feb-17 | Disposition | 42,834 | -- | -- | (100%) 42.83K to 0 | |
| 29-Jun-16 4:25 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 28-Jun-16 | Market Option Sale | 6,012 | $7.05 | $42,384.60 | (17%) 35.93K to 29.92K | (238%) |
| 29-Jun-16 4:25 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 27-Jun-16 | Option Exercise | 19,166 | -- | -- | 114% 16.76K to 35.93K | |
| 02-May-16 5:29 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 29-Apr-16 | Payment of Exercise | 5,634 | $7.18 | $40,452.10 | (25%) 22.4K to 16.76K | (231%) |
| 02-May-16 5:29 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 29-Apr-16 | Option Exercise | 17,334 | -- | -- | 342% 5.06K to 22.4K | |
| 18-Mar-16 4:04 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Mar-16 | Payment of Exercise | 2,438 | $6.21 | $15,140.00 | (33%) 7.5K to 5.06K | (283%) |
| 18-Mar-16 4:04 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Mar-16 | Option Exercise | 7,500 | $6.21 | $46,575.00 | 100% 0 to 7.5K | 283% |
| 07-Feb-17 4:59 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 25-Jun-15 | Payment of Exercise | 6,249 | $8.69 | $54,303.80 | (13%) 49.08K to 42.83K | |
| 07-Feb-17 4:59 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 25-Jun-15 | Option Exercise | 19,167 | -- | -- | 64% 29.92K to 49.08K |